AusPAR: Opdivo

Australian Public Assessment Report

AusPAR

AusPAR: Opdivo [PDF, 603.01 KB]

AusPAR: Opdivo [Word, 748.5 KB]

AusPAR Attachment 1: Product Information for Opdivo [PDF, 2.45 MB]

AusPAR Attachment 1: Product Information for Opdivo [Word, 4.3 MB]

Device/Product Name

Opdivo

Active ingredients

Nivolumab

AusPAR Date

6 June 2023

Published

9 June 2023

Submission Number

PM-2021-02518-1-4

Submission Type

Extension of indication

Decision

Approved